Oncology/Cancer Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067229
  • December 2021
  • Pharmaceuticals
  • 254 Pages
Report Description

This report is a comprehensive study that examines the Oncology/Cancer Drugs industry in depth. With reference to key regions and major nations, the study specifies the product type of Oncology/Cancer Drugs as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Oncology/Cancer Drugs market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Oncology/Cancer Drugs market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Oncology/Cancer Drugs market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Oncology/Cancer Drugs Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Oncology/Cancer Drugs market study. The market dynamics and factors such as the threat of a Oncology/Cancer Drugs substitute, the threat of new entrants into the Oncology/Cancer Drugs market, buyer bargaining power, supplier bargaining power to Oncology/Cancer Drugs providing companies, and internal rivalry among Oncology/Cancer Drugs providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Oncology/Cancer Drugs market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Oncology/Cancer Drugs industry.
 
Oncology/Cancer Drugs Market Key Trends Analysis

The important factors influencing the growth of the Oncology/Cancer Drugs market have been examined in this report. The driving factors that are boosting demand for Oncology/Cancer Drugss and the restraining factors that are slowing growth of the Oncology/Cancer Drugs industry are addressed in depth, as well as their implications for the worldwide Oncology/Cancer Drugs market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Oncology/Cancer Drugs Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Oncology/Cancer Drugs industry. On the basis of current and future trends, all segments of the Oncology/Cancer Drugs industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Oncology/Cancer Drugs Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Oncology/Cancer Drugs market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Oncology/Cancer Drugs market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Oncology/Cancer Drugs market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Oncology/Cancer Drugs market. All important stakeholders in the Oncology/Cancer Drugs value chain and technological ecosystem are expected to benefit from the insights offered in the Oncology/Cancer Drugs market research study.

In order to provide a broader understanding of the top competitors in the Oncology/Cancer Drugs market, the research includes a company market share analysis. AbbVie Inc., Amgen, Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson (Janssen Global Services, LLC,), Merck & Co., Inc., Novartis AG, Pfizer Inc. are among the major participants in the global Oncology/Cancer Drugs industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered AbbVie Inc., Amgen, Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson (Janssen Global Services, LLC,), Merck & Co., Inc., Novartis AG, Pfizer Inc.
 
Major Highlights of the Oncology/Cancer Drugs Market report study:
  • An in-depth examination of the global Oncology/Cancer Drugs industry will be published soon.
  • The study examines the global Oncology/Cancer Drugs market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Oncology/Cancer Drugs industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Oncology/Cancer Drugs market is being shaped by several major trends.
  • The size of the Oncology/Cancer Drugs market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Oncology/Cancer Drugs market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Oncology/Cancer Drugs market as follows:
Global Oncology/Cancer Drugs Market: By Product Type

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy

Global Oncology/Cancer Drugs Market: By Application
  • Lung Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Liver Cancer
  • Esophagus Cancer
  • Cervical Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Other Cancers

Global Oncology/Cancer Drugs Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Oncology/Cancer Drugs market.
  • Universities and students
  • Other companies in the Oncology/Cancer Drugs market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Oncology/Cancer Drugs market

Manufacturers and Segments

  • AbbVie Inc.
  • Amgen
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson (Janssen Global Services, LLC,)
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Lung Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Liver Cancer
  • Esophagus Cancer
  • Cervical Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Other Cancers

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Oncology/Cancer Drugs Market Snapshot
          2.1.1. Global Oncology/Cancer Drugs Market By Chemotherapy,2019
               2.1.1.1.
               2.1.1.2.Chemotherapy
               2.1.1.3.Targeted Therapy
               2.1.1.4.Immunotherapy (Biologic Therapy)
          2.1.2. Global Oncology/Cancer Drugs Market By Lung Cancer,2019
               2.1.2.1.
               2.1.2.2.Lung Cancer
               2.1.2.3.Stomach Cancer
               2.1.2.4.Colorectal Cancer
               2.1.2.5.Breast Cancer
               2.1.2.6.Prostate Cancer
               2.1.2.7.Liver Cancer
               2.1.2.8.Esophagus Cancer
               2.1.2.9.Cervical Cancer
               2.1.2.10.Kidney Cancer
               2.1.2.11.Bladder Cancer
          2.1.3. Global Oncology/Cancer Drugs Market By End-use,2019
          2.1.4. Global Oncology/Cancer Drugs Market By Geography,2019

3. Global Oncology/Cancer Drugs Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Oncology/Cancer Drugs Market Size (US$), By Chemotherapy, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Chemotherapy, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Chemotherapy, 2020
     4.2. Global Oncology/Cancer Drugs Market Size (US$), By Chemotherapy, 2018 – 2028

5. Global Oncology/Cancer Drugs Market Size (US$), By Lung Cancer, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Lung Cancer, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Lung Cancer, 2020
     5.2. Global Oncology/Cancer Drugs Market Size (US$), By Lung Cancer, 2018 – 2028

6. Global Oncology/Cancer Drugs Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Oncology/Cancer Drugs Market Size (US$), By End-use, 2018 – 2028

7. Global Oncology/Cancer Drugs Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Oncology/Cancer Drugs Market Analysis, 2018 – 2028 
          7.2.1. North America Oncology/Cancer Drugs Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Oncology/Cancer Drugs Market Size (US$), By Chemotherapy, 2018 – 2028
          7.2.3. North America Oncology/Cancer Drugs Market Size (US$), By Lung Cancer, 2018 – 2028
          7.2.4. North America Oncology/Cancer Drugs Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Oncology/Cancer Drugs Market Analysis, 2018 – 2028 
          7.3.1.  Europe Oncology/Cancer Drugs Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Oncology/Cancer Drugs Market Size (US$), By Chemotherapy, 2018 – 2028
          7.3.3. Europe Oncology/Cancer Drugs Market Size (US$), By Lung Cancer, 2018 – 2028
          7.3.4. Europe Oncology/Cancer Drugs Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Oncology/Cancer Drugs Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Oncology/Cancer Drugs Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Oncology/Cancer Drugs Market Size (US$), By Chemotherapy, 2018 – 2028
          7.4.3. Asia Pacific Oncology/Cancer Drugs Market Size (US$), By Lung Cancer, 2018 – 2028
          7.4.4. Asia Pacific Oncology/Cancer Drugs Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Oncology/Cancer Drugs Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Oncology/Cancer Drugs Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Oncology/Cancer Drugs Market Size (US$), By Chemotherapy, 2018 – 2028
          7.5.3. Latin America Oncology/Cancer Drugs Market Size (US$), By Lung Cancer, 2018 – 2028
          7.5.4. Latin America Oncology/Cancer Drugs Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Oncology/Cancer Drugs Market Analysis, 2018 – 2028 
          7.6.1.  MEA Oncology/Cancer Drugs Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Oncology/Cancer Drugs Market Size (US$), By Chemotherapy, 2018 – 2028
          7.6.3. MEA Oncology/Cancer Drugs Market Size (US$), By Lung Cancer, 2018 – 2028
          7.6.4. MEA Oncology/Cancer Drugs Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Oncology/Cancer Drugs Providers
        8.4.1 AbbVie Inc.
                8.4.1.1 Business Description
                8.4.1.2 AbbVie Inc. Geographic Operations
                8.4.1.3 AbbVie Inc. Financial Information
                8.4.1.4 AbbVie Inc. Product Positions/Portfolio
                8.4.1.5 AbbVie Inc. Key Developments
        8.4.2 Amgen
                8.4.2.1 Business Description
                8.4.2.2 Amgen Geographic Operations
                8.4.2.3 Amgen Financial Information
                8.4.2.4 Amgen Product Positions/Portfolio
                8.4.2.5 Amgen Key Developments
        8.4.3 Astellas Pharma Inc.
                8.4.3.1 Business Description
                8.4.3.2 Astellas Pharma Inc. Geographic Operations
                8.4.3.3 Astellas Pharma Inc. Financial Information
                8.4.3.4 Astellas Pharma Inc. Product Positions/Portfolio
                8.4.3.5 Astellas Pharma Inc. Key Developments
        8.4.4 AstraZeneca PLC
                8.4.4.1 Business Description
                8.4.4.2 AstraZeneca PLC Geographic Operations
                8.4.4.3 AstraZeneca PLC Financial Information
                8.4.4.4 AstraZeneca PLC Product Positions/Portfolio
                8.4.4.5 AstraZeneca PLC Key Developments
        8.4.5 Bristol-Myers Squibb Company
                8.4.5.1 Business Description
                8.4.5.2 Bristol-Myers Squibb Company Geographic Operations
                8.4.5.3 Bristol-Myers Squibb Company Financial Information
                8.4.5.4 Bristol-Myers Squibb Company Product Positions/Portfolio
                8.4.5.5 Bristol-Myers Squibb Company Key Developments
        8.4.6 F. Hoffmann-La Roche Ltd.
                8.4.6.1 Business Description
                8.4.6.2 F. Hoffmann-La Roche Ltd. Geographic Operations
                8.4.6.3 F. Hoffmann-La Roche Ltd. Financial Information
                8.4.6.4 F. Hoffmann-La Roche Ltd. Product Positions/Portfolio
                8.4.6.5 F. Hoffmann-La Roche Ltd. Key Developments
        8.4.7 Johnson & Johnson (Janssen Global Services, LLC,)
                8.4.7.1 Business Description
                8.4.7.2 Johnson & Johnson (Janssen Global Services, LLC,) Geographic Operations
                8.4.7.3 Johnson & Johnson (Janssen Global Services, LLC,) Financial Information
                8.4.7.4 Johnson & Johnson (Janssen Global Services, LLC,) Product Positions/Portfolio
                8.4.7.5 Johnson & Johnson (Janssen Global Services, LLC,) Key Developments
        8.4.8 Merck & Co., Inc.
                8.4.8.1 Business Description
                8.4.8.2 Merck & Co., Inc. Geographic Operations
                8.4.8.3 Merck & Co., Inc. Financial Information
                8.4.8.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.8.5 Merck & Co., Inc. Key Developments
        8.4.9 Novartis AG
                8.4.9.1 Business Description
                8.4.9.2 Novartis AG Geographic Operations
                8.4.9.3 Novartis AG Financial Information
                8.4.9.4 Novartis AG Product Positions/Portfolio
                8.4.9.5 Novartis AG Key Developments
        8.4.10 Pfizer Inc.
                8.4.10.1 Business Description
                8.4.10.2 Pfizer Inc. Geographic Operations
                8.4.10.3 Pfizer Inc. Financial Information
                8.4.10.4 Pfizer Inc. Product Positions/Portfolio
                8.4.10.5 Pfizer Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Oncology/Cancer Drugs Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Oncology/Cancer Drugs Market Revenue, By Chemotherapy, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Oncology/Cancer Drugs Market Revenue, By Lung Cancer, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Oncology/Cancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Oncology/Cancer Drugs Market Revenue, By Chemotherapy, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Oncology/Cancer Drugs Market Revenue, By Lung Cancer, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Oncology/Cancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Oncology/Cancer Drugs Market Revenue, By Chemotherapy, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Oncology/Cancer Drugs Market Revenue, By Lung Cancer, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Oncology/Cancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Oncology/Cancer Drugs Market Revenue, By Chemotherapy, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Oncology/Cancer Drugs Market Revenue, By Lung Cancer, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Oncology/Cancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Oncology/Cancer Drugs Market Revenue, By Chemotherapy, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Oncology/Cancer Drugs Market Revenue, By Lung Cancer, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Oncology/Cancer Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Oncology/Cancer Drugs: Market Segmentation 
FIG. 2 Global Oncology/Cancer Drugs Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Oncology/Cancer Drugs Market, By Chemotherapy, 2019 (US$ Mn) 
FIG. 5 Global Oncology/Cancer Drugs Market, By Lung Cancer, 2019 (US$ Mn) 
FIG. 6 Global Oncology/Cancer Drugs Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Oncology/Cancer Drugs Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Oncology/Cancer Drugs Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Oncology/Cancer Drugs Providers, 2019
FIG. 11 Global Oncology/Cancer Drugs Market Revenue Contribution, By Chemotherapy, 2019 & 2028 (Value %) 
FIG. 12 Global Oncology/Cancer Drugs Market Revenue Contribution, By Lung Cancer, 2019 & 2028 (Value %) 
FIG. 13 Global Oncology/Cancer Drugs Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Oncology/Cancer Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Oncology/Cancer Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Oncology/Cancer Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Oncology/Cancer Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Oncology/Cancer Drugs Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Oncology/Cancer Drugs market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Oncology/Cancer Drugs Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Oncology/Cancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE  North America Oncology/Cancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE  North America Oncology/Cancer Drugs Market Value, By Country, 2018 – 2028
TABLE  Europe Oncology/Cancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Europe Oncology/Cancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Europe Oncology/Cancer Drugs Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Oncology/Cancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Oncology/Cancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Oncology/Cancer Drugs Market Value, By Country, 2018 – 2028
TABLE  Latin America Oncology/Cancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Oncology/Cancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Oncology/Cancer Drugs Market Value, By Country, 2018 – 2028
TABLE  MEA Oncology/Cancer Drugs Market Value, By Segment1, 2018 – 2028
TABLE  MEA Oncology/Cancer Drugs Market Value, By Segment2, 2018 – 2028
TABLE  MEA Oncology/Cancer Drugs Market Value, By Country, 2018 – 2028
TABLE  AbbVie Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Amgen: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Astellas Pharma Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-Myers Squibb Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson (Janssen Global Services, LLC,): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Oncology/Cancer Drugs Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Oncology/Cancer Drugs Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Oncology/Cancer Drugs Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Oncology/Cancer Drugs Market, By Geography, 2019 (US$ Mn)
FIG.  Global Oncology/Cancer Drugs Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Oncology/Cancer Drugs Providers, 2016
FIG.  Global Oncology/Cancer Drugs Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Chemotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Targeted Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Immunotherapy (Biologic Therapy) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Hormonal Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Oncology/Cancer Drugs Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Lung Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Stomach Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Colorectal Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Breast Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Prostate Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Liver Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Esophagus Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Cervical Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Kidney Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Bladder Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Other Cancers Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Oncology/Cancer Drugs Market Value, 2018 – 2028, (US$ Mn)